We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Sarah
Hughes
s.e.hughes@bham.ac.uk
Sarah
Hughes
s.e.hughes@bham.ac.uk
Sarah
Hughes
s.e.hughes@bham.ac.uk
Sequelae of infectious and parasitic diseasesProvisional assignment of new diseases of uncertain etiology
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
What’s the problem?
Long-term symptoms of COVID-19 infection are called 'Long COVID'. Up to 14% of children and young people who catch COVID-19 have Long COVID symptoms 3-months later. Long COVID includes over 200 different symptoms that involve different body systems. Having symptoms that involve multiple body systems can also occur when people have long-term health conditions. Up to 30% of children and young people are thought to have two or more long-term conditions. Having a single questionnaire to measure symptoms will help evaluate these different conditions in children and young people.
Symptom questionnaires are available for adults,but these do not measure impacts unique to young people such as effects on schoolwork or development. There are no questionnaires for young people that measure symptoms of long COVID or other conditions that involve multiple body systems.
What’s the solution?
The Symptom Burden Questionnaire™ for Long COVID is a questionnaire that measures Long COVID symptoms in adults. It measures over 100 symptoms across different body systems (for example,breathing symptoms,digestive symptoms). We aim to adapt this questionnaire to make it suitable for young people (11-17 years) who are living with Long COVID or other long-term health conditions.
How will we do this?
First,we will adapt the questionnaire to make sure it includes symptoms important to young people. Second,we will test the questionnaire to understand how well it measures symptoms.
Part 1:
• Healthcare professionals and researchers will review the questionnaire to check if it is suitable for young people. We will remove unsuitable questions and add new questions if needed.
Part 2:
• Up to 400 young people will answer the adapted questionnaire and a short survey to get their views on how easy it is to complete the questionnaire. They will complete the questionnaire and the survey using their mobile phone,tablet,or computer.
• We will use their answers to improve the questionnaire's design and to describe how well it measures symptoms in young people. We will do this using statistical tests.
Patient and public involvement and engagement
People with Long COVID and young people helped to design this research. Young people will work with us on each part of the study.
How will we share the results?
We will present the results at conferences and publish them in a scientific journal. We will share them with young people,parents/carers,schools,health professionals,and the public. The adapted questionnaire will be available for researchers and healthcare professionals to use. They can use the questionnaire in clinics to measure symptoms of long-term conditions in young people and in research studies (for example,to find out if new treatments are safe and effective).
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Validation of outcome measures;
You can take part if:
You may not be able to take part if:
Individuals <11 years and >18 years of age Unable to read English at a reading age of 12 years Parent/carer does not give their informed consent
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Sarah
Hughes
s.e.hughes@bham.ac.uk
Sarah
Hughes
s.e.hughes@bham.ac.uk
Sarah
Hughes
s.e.hughes@bham.ac.uk
The study is sponsored by University of Birmingham and funded by NIHR Central Commissioning Facility (CCF) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 54544
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
